Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

TYSON MEDICAL INC

NPI: 1376053843 · EL CENTRO, CA 92243 · Family Medicine Physician · NPI assigned 10/10/2017

$8.01M
Total Medicaid Paid
190,824
Total Claims
174,940
Beneficiaries
90
Codes Billed
2018-04
First Month
2024-12
Last Month

Provider Details

Authorized OfficialTYSON, BRIAN (CEO)
NPI Enumeration Date10/10/2017

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,747 $155K
2019 9,058 $519K
2020 25,766 $824K
2021 37,465 $1.24M
2022 37,600 $1.55M
2023 43,704 $1.85M
2024 35,484 $1.87M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 40,760 36,650 $4.19M
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 14,748 14,694 $1.41M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 11,228 10,242 $1.03M
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 5,558 5,536 $473K
99215 Prolong outpt/office vis 2,621 2,333 $246K
99205 Prolong outpt/office vis 2,769 2,745 $233K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 13,430 12,725 $98K
S9088 Services provided in an urgent care center (list in addition to code for service) 1,098 1,001 $84K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 10,382 9,533 $58K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 11,690 10,119 $28K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 5,355 4,765 $20K
94760 12,165 10,610 $17K
86328 3,374 3,112 $12K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 7,529 6,426 $12K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2,984 2,957 $10K
99072 11,145 9,598 $9K
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel 1,064 961 $7K
81001 3,581 3,482 $7K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 958 933 $6K
71046 Radiologic examination, chest; 2 views 2,021 1,939 $5K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1,166 1,148 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg 7,744 6,615 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 448 439 $4K
99195 625 620 $4K
97597 613 486 $3K
93000 740 733 $3K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 267 224 $3K
81025 1,678 1,645 $3K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 996 974 $3K
J0696 Injection, ceftriaxone sodium, per 250 mg 1,722 1,573 $2K
73130 671 668 $2K
73630 582 578 $1K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 690 678 $1K
79403 57 57 $1K
73610 397 394 $1K
90715 148 148 $910.71
99000 414 402 $689.41
86318 528 507 $555.20
81003 1,097 1,056 $538.12
85025 Blood count; complete (CBC), automated, and automated differential WBC count 732 729 $483.75
73110 117 116 $455.21
82962 500 486 $451.33
72110 26 25 $408.38
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 687 610 $406.59
87807 606 590 $400.76
80053 Comprehensive metabolic panel 504 503 $391.83
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 24 24 $359.04
74018 166 164 $352.06
73560 210 208 $316.88
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 28 28 $258.68
74022 53 53 $217.10
29540 41 41 $158.14
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 27 27 $149.46
69210 27 27 $139.82
77086 42 42 $136.30
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 171 170 $134.85
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 338 337 $134.57
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 13 13 $125.20
87631 39 37 $125.00
87279 26 26 $125.00
J7030 Infusion, normal saline solution , 1000 cc 160 156 $95.54
96373 54 54 $59.55
J1200 Injection, diphenhydramine hcl, up to 50 mg 101 99 $49.29
J8540 Dexamethasone, oral, 0.25 mg 96 96 $12.12
82247 14 13 $9.07
86308 42 41 $8.28
84460 14 13 $4.53
84450 14 13 $4.37
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 13 12 $4.33
82565 14 13 $4.27
84075 14 13 $4.09
82310 14 13 $4.06
82040 14 13 $3.98
84550 14 13 $3.97
84295 27 26 $3.47
84132 27 26 $3.41
84520 14 13 $3.12
84155 14 13 $2.93
36415 Collection of venous blood by venipuncture 215 215 $2.15
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 29 28 $1.78
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 17 17 $0.28
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 35 35 $0.06
36416 300 297 $0.00
87276 26 26 $0.00
86140 15 15 $0.00
72100 13 12 $0.00
J2405 Injection, ondansetron hydrochloride, per 1 mg 31 31 $0.00
87275 38 38 $0.00
82947 13 12 $0.00
10060 12 12 $0.00